pet/spect scan

PROCEDURE2 trials

Sponsors

GlaxoSmithKline, Jeffrey A. Lieberman, MD

Conditions

Schizophrenia

Unknown Phase

A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

CompletedNCT00392743

GlaxoSmithKlineSchizophrenia

Start: 2006-12-31End: 2007-05-31Updated: 2012-11-05

PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations

TerminatedNCT02983058

Jeffrey A. Lieberman, MDSchizophrenia

Start: 2016-11-30End: 2017-07-31Updated: 2020-06-02